Nonetheless, pathological elevation of blood glucose in moderate and severe COVID-19 patients has been linked to enhanced hepatic gluconeogenesis by the activity of the Golgi protein GP73, which is found to be elevated in the plasma of infected patients37. Here, GOLM1 is linked to COVID-19.